potential indications for glp-1 receptor agonists keep expanding in Solid Tumour Therapy: Exploring Their Anticancer and Underlying Molecular Pathways Exploring the Side Effects of
Description
Furthermore, the high price of GLP-1 drugs and restricted insurance coverage create accessibility challenges, particularly in lower-income populations
Scientists later identified that hormone as glucagon-like peptide 1GLP-1
[147] It is also available for obesity, limited to treatment for two years
doi: 10.1126/science.270.5240.1326 95 BobustucGCKassamABRovinRAJeudySSmithJSIsleyBet al
doi: 10.2337/diab.6.3.234
Multiple sclerosis patients taking glucagon-like peptide-1 receptor (GLP-1) agonists: a single-institution retrospective cohort study of tolerability and weight loss
